Vilin Bio Med (NSE:VILINBIO) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:VILINBIO Vilin Bio Med Ltd NSE:VILINBIO
69 GF Score
Price ₹44.70
GF Value ₹75.10
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Vilin Bio Med Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Vilin Bio Med Valuation Rank Related Terms

NSE:VILINBIO
69GF Score
Vilin Bio Med Ltd NSE:VILINBIO
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Vilin Bio Med (NSE:VILINBIO) Overvalued in 2026?

Based on GuruFocus' analysis, Vilin Bio Med stock appears to be undervalued. The current stock price of ₹44.70 is trading 40.5% below its estimated GF Value™ of ₹75.10. GuruFocus considers Vilin Bio Med to be Possible Value Trap.

Key valuation signals for NSE:VILINBIO:

  • Valuation Rank:
  • GF Value™: ₹75.10 vs. price of ₹44.70 (40.5% below fair value)
  • GF Score™: 69/100 with 4 warning signs

No single metric tells the full story. See the NSE:VILINBIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vilin Bio Med Business Description

Address Road No. 2, Banjara Hills, H. No. 8-2-269/S/43, Plot No. 43, Sagar Co-operative Housing Society, Khairatabad, Hyderabad, TG, IND, 500034
Vilin Bio Med Ltd is engaged in the domestic business of manufacturing Pharmaceuticals products. It is manufacturing pharmaceutical formulations such as Oral Liquids, Dry syrups, Sachets, External Preparations, Beta and Non-Beta Lactam tablets, and Capsules and Nutritional Food supplements.
69GF Score

Get the complete analysis for NSE:VILINBIO

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹44.70
Price
₹75.10
GF Value